Clinical data were obtained from a publicly available ovarian cancer dataset by Tothill et al.[47] Our analysis revealed that the expression of CD163 and CD206 alone did not significantly impact overall survival (Figure S8C,D, Supporting Information). This evidence concerns the gene MRC1 and ovarian cancer.